Bayer Gambles on Science to Let It Keep Selling Roundup, Mitigate Future Claims

FRANKFURT/NEW YORK— Seeking to forestall further claims, Bayer AG is taking a risky bet that an independent scientific review will ultimately show that its widely used weed killer Roundup does not cause cancer, legal experts said. The company on Wednesday …

from News – Insurance Journal